A new mathematical formula for cancer progression

Nov 09, 2007

Tumor progression can now be mapped less to mathematical standards and more to individual patients according to a new study by researchers at Harvard and Johns Hopkins Universities. The study, publishing in PLoS Computational Biology on November 9, 2007, provides a new paradigm in calculating tumor development, showing that it appears to be driven by mutations in many genes.

Our understanding of the progression of cancer has long been based on streamlined models where cancer is driven by mutations in only a few genes. Niko Beerenwinkel et al. show how tumor progression can be driven by hundreds of genes. As many as 20 different mutated genes might be responsible for driving an individual tumor’s development.

Beerenwinkel et al. used a case of colon cancer to derive their results. Cancer progression proceeds stochastically from a single genetically altered cell to billions of invasive cells through a series of clonal expansions. According to their model, cancer progression is driven by mutations in many genes, each of which confers only a small selective advantage. It was found that the time it takes for a benign tumor to transform into a malignant tumor is dominated by the selective advantage per mutation and by the number of cancer genes, whereas tumor size and mutation rate have smaller impacts.

This new model could help explain the large amount of variation between individual tumors that has long puzzled researchers and clinicians. The increasing amount of high-throughput molecular data that is being generated has resulted in new challenges for understanding complex biosystems such as cancer. New mathematical models like this one can provide unique insights that simplify interpretation and at the same time answer important biomedical questions.

Source: Public Library of Science

Explore further: Two-week international diet swap shows potential effects of food on colon cancer risk

Related Stories

High fidelity: Researcher finds keys to genome integrity

Apr 14, 2015

Maintaining the stability and the correct sequence of our genetic information is vital to the accurate transmission of our genetic code. However, in the course of replicating, our DNA frequently runs into ...

Hippo 'crosstalk' may be vital to tumor suppression

Mar 09, 2015

Think of a waterfall, and you might see why cell-signaling pathways are important to cancer research. As water cascades, it impacts everything downstream. And everything upstream affects the waterfall.

We're all mammals – so why do we look so different?

Feb 23, 2015

It is easy to distinguish a mouse from a cow. But for members of the same class of mammal, where do such differences begin? In 2011, scientists discovered there were differences in cow and mice blastocysts, the ti ...

End of CRISPR-CAS9 controversy

Feb 10, 2015

The IBS research team (Center for Genome Engineering) has successfully confirmed that CRISPR-Cas9 has accurate on-target effects in human cells, through joint research with the Seoul National University College ...

Recommended for you

What's the harm in alternative therapies?

5 hours ago

We often see stories in the media about cancer patients who have chosen alternative treatments, either alongside or instead of conventional treatment.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.